Trials / Completed
CompletedNCT05378295
Personalized Fiber and Insulin Sensitivity
Personalized Microbial Substrates to Prevent Type 2 Diabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Maastricht University Medical Center · Academic / Other
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
In this project the investigators intend to study the therapeutic potential of a personalized fibre mixture in individuals at high risk of developing T2DM, and aim to address the following key objectives: 1. To investigate whether a mixture of fermentable fibres, which differ in DP and side chains, will stimulate a broad range of SCFA-producing bacterial genera, resulting in enhanced chronic SCFA production throughout the whole colon with a large variation between individuals; 2. To unravel whether providing personalized fibre mixtures, selected based on the individuals' initial microbiota and capacity for SCFA production is crucial to successfully improve host insulin sensitivity and metabolic health
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Fermentable oligosaccharide | Supplementation period 12 weeks |
| DIETARY_SUPPLEMENT | Personalized fiber mixture | Supplementation period 12 weeks |
Timeline
- Start date
- 2021-11-05
- Primary completion
- 2024-04-22
- Completion
- 2024-04-22
- First posted
- 2022-05-18
- Last updated
- 2024-04-23
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT05378295. Inclusion in this directory is not an endorsement.